Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 2 , Pages 119-127 , June 2005

Photopheresis up-regulates CD36 on monocytes and reduces CD25+ and CD28+ T cell numbers

References 

  1. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med. 1987;316:297–303
  2. Richter HI, Stege H, Ruzicka T, Soehnger D, Heyll A, Krutmann J. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. J Am Acad Dermatol. 1997;36:787–789
  3. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994;14:845–848
  4. Berger CL, Xu AL, Hanlon D, et al. Induction of human tumor-loaded dendritic cells. Int J Cancer. 2001;91:438–447
  5. Marks DI, Fox RM. Mechanisms of photochemotherapy-induced apoptotic cell death in lymphoid cells. Biochem Cell Biol. 1991;69:754–760
  6. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol. 1996;107:235–242
  7. Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T cell lymphoma and graft versus host disease patients. Br J Haematol. 1999;107:707–711
  8. Hanlon DJ, Berger CL, Edelson RL. Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int J Cancer. 1998;78:70–75
  9. Tambur AR, Ortegel JW, Morales A, Klingemann H, Gebel HM, Tharp MD. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc. 2000;32:747–748
  10. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;48:2207–2216
  11. Bladon J, Taylor PC. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. J Clin Aph. 2002;17:177–182
  12. Bladon J, Taylor PC. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction. Transplant Proc. 2003;35:1328–1332
  13. Fadok VA, Warner ML, Bratton DL, Henson PM. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (αvβ3). J Immunol. 1998;161:6250–6257
  14. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin. Immunity. 2001;14:303–313
  15. Trautinger F, Kokesch C, Klosner G, Knobler RM, Kinda-Mügge I. Expression of the 72-kD heat shock protein is induced by ultraviolet A radiation in a human fibrosarcoma cell line. Exp Dermatol. 1999;8:187–192
  16. Binder RJ, Anderson KM, Basu S, Srivastava PK. Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol. 2000;165:6029–6035
  17. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med. 1998;4:581–587
  18. Schwartz RH, Mueller DL, Jenkins MK, Quill H. T-cell clonal anergy. Cold Spring Harb Symph Quant Biol. 1989;54:605–610
  19. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity. 1997;7:445–450
  20. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol. 2001;2:1010–1017
  21. Belz GT, Carbone FR, Heath WR. Cross-presentation of antigens by dendritic cells. Crit Rev Immunol. 2002;22:439–448
  22. Bladon J, Taylor PC. Mononuclear cells treated by extracorporeal photopheresis do not express heat shock proteins 70(72). Br J Haematol. 2002;117(Suppl. 1):71;[abstract]
  23. Fimiani M, Rubegni P, Pimpinelli N, Mori M, De Aloe G, Andreassi L. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides. Dermatology. 1997;194:107–110
  24. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidised low density lipoproteins. J Biol Chem. 1993;26:11811–118116
  25. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull. 1997;53:491–508
  26. Hughes J, Lui Y, Van Damme J, Savill J. Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor/thrombospondin recognition mechanism that is uncoupled from chemokine secretion. J Immunol. 1997;158:4389–4397
  27. Albert ML, Pearce SF, Francisco LM, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998;188:1359–1368
  28. Bladon J, Taylor PC. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes. J Photochem Photobiol: B Biol. 2003;69:129–138
  29. Parkman R. Chronic graft-versus-host disease. Curr Opin Haem. 1998;5:22–25
  30. Kobayashi S, Hashino DS, Tanaka A, et al. Increased adhesion molecule expression during graft versus host disease. Transplant Proc. 2000;32:2452–2453
  31. Lucas PJ, Negishi I, Nakayama K, Fields LE, Loh DY. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol. 1995;154:5757–5768
  32. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibit graft-versus-host disease lethality. Blood. 2002;99:3493–3499
  33. Clark FJ, Gregg R, Piper K, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+C25high regulatory T cells. Blood. 2004;103:2410–2416
  34. Bladon J, Taylor PC. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells respectively. J Cut Surg Med. 2004;8:148–156
  35. Mrowietz U, Zhu K, Christophers E. Treatment of severe psoriasis with anti-CD25 monoclonal antibodies. Arch Dermatol. 2000;136:675–676
  36. Willenbacher W, Basara N, Blau IW, Fauser AA, Kiehl MG. Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab. Br J Haematol. 2001;112:820–823
  37. Bernengo MG, Fierro MT, Novelli M, Lisa F, Appino A. Soluble interleukin-2 receptor in Sezary syndrome: its origin and clinical application. Br J Dermatol. 1993;128:124–129
  38. Takemoto S, Mulloy JC, Cereseto A, et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA. 1997;94:13897–13902
  39. Nicot C, Mulloy JC, Ferrari MG, et al. HTLV-1 p12I proteins enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood. 2001;98:823–829
  40. Zamorano J, Wang HY, Wang R, Shi Y, Longmore GD, Keegan AD. Regulation of cell growth by IL2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol. 1998;160:3502–3512

PII: S1572-1000(05)00034-7

doi: 10.1016/S1572-1000(05)00034-7

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 2 , Pages 119-127 , June 2005

Article Tools

* Image Usage & Resolution